PREVALENCE OF OBSTRUCTIVE SLEEP APNEA DETERMINED BY THE WATCHPAT IN NONOBESE JAPANESE PATIENTS WITH POOR GLUCOSE CONTROL AND TYPE 2 DIABETES.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Minori ShinodaYasuo Terauchi

Abstract

Diagnosing obstructive sleep apnea (OSA) usually involves high cost, patient inconvenience, and the need for examination at a specialized center. This study employed a portable, wearable, diagnostic device (WatchPAT) to investigate the prevalence of OSA in nonobese Japanese patients with type 2 diabetes. Patients with type 2 diabetes were tested for OSA over one night using the WatchPAT. Logistic regression analysis was used to estimate the odds ratios (ORs) of risk factors for OSA in nonobese subjects. A total of 200 eligible patients with type 2 diabetes were studied (64.5% men; aged 60.1 ± 13.6 years; body mass index [BMI], 26.3 ± 5.2 kg/m2). When OSA was defined as apnea-hypopnea index ≥5/hour, its prevalence was 80.5%. The prevalence of OSA in subjects with a BMI <20 kg/m2, ≥20 and <25 kg/m2, ≥25 and <30 kg/m2, and ≥30 kg/m2 was 38.9%, 73.5%, 86.5%, and 97.5%, respectively. The severity of OSA increased in proportion to BMI, especially when the BMI was >25 kg/m2. The prevalence of OSA was also high (66.3%) in normal-weight subjects (BMI <25 kg/m2). Furthermore, the serum triglyceride level (OR, 1.01; 95% confidence interval, 1.00 to 1.02; P = .042) was significantly related to OSA. A high prevalence of OSA was observed in ...Continue Reading

References

Nov 1, 1995·Current Opinion in Pulmonary Medicine·M Partinen
Jul 29, 2003·The European Respiratory Journal·N MeslierJ L Racineux
Sep 1, 2005·Obesity Research·Maria Rosario G Araneta, Elizabeth Barrett-Connor
Jun 12, 2008·Diabetes Research and Clinical Practice·Jonathan E ShawUNKNOWN International Diabetes Federation Taskforce on Epidemiology and Prevention
Mar 13, 2009·Diabetes Care·Gary D FosterUNKNOWN Sleep AHEAD Research Group
Nov 17, 2009·Metabolism: Clinical and Experimental·Susumu KashineIichiro Shimomura
Dec 19, 2009·American Journal of Respiratory and Critical Care Medicine·Renee S AronsohnEsra Tasali
Jan 30, 2010·The European Respiratory Journal·K YamagishiT Tanigawa
Jun 18, 2011·The Clinical Respiratory Journal·Anne-Katrin SchoberIgor Alexander Harsch
Sep 3, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Wen Bun LeongShahrad Taheri
Oct 18, 2013·Clinical and Experimental Nephrology·Takashi WadaUNKNOWN Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan
Apr 18, 2014·Nature and Science of Sleep·Eyal Shahar
Mar 22, 2016·Physiological Measurement·Da Woon JungKwang Suk Park
Nov 1, 2016·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Yijin Jereme GanYaw Khian Chong
Feb 7, 2017·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Amin AminAbd A Tahrani

❮ Previous
Next ❯

Citations

Jul 1, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Satoru YamadaHiroyasu Nishikawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2022 Meta ULC. All rights reserved